{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:48:11Z","timestamp":1791920891225,"version":"4.3.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL169015"],"award-info":[{"award-number":["R01HL169015"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG062393"],"award-info":[{"award-number":["R01AG062393"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG069575"],"award-info":[{"award-number":["R01AG069575"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11886-024-02186-4","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T06:51:01Z","timestamp":1744613461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cardiovascular Outcomes After Acute Coronary Syndrome in Persons Living with HIV: A Scoping Review"],"prefix":"10.1007","volume":"27","author":[{"given":"David","family":"Iskhakov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie N.","family":"Deleger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Plutzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia A.","family":"Triant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily P.","family":"Hyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"2186_CR1","unstructured":"HIV data and statistics. https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/strategic-information\/hiv-data-and-statistics. Accessed 30 May 2024."},{"issue":"12","key":"2186_CR2","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/cid\/ciu701","volume":"59","author":"J Schouten","year":"2014","unstructured":"Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, Prins M, Reiss P, AGEhIV Cohort Study Group. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the agehiv cohort study. Clin Infect Dis. 2014;59(12):1787\u201397.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2186_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","volume":"43","author":"FJ Palella","year":"2006","unstructured":"Palella FJ, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holmberg SD, HIV Outpatient Study Investigators. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43(1):27\u201334.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"2186_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.amjcard.2015.10.030","volume":"117","author":"MJ Feinstein","year":"2016","unstructured":"Feinstein MJ, Bahiru E, Achenbach C, Longenecker CT, Hsue P, So-Armah K, Freidberg MS, Lloyd-Jones DM. Patterns of cardiovascular mortality for HIV-infected adults in the United States: 1999 to 2013. Am J Cardiol. 2016;117(2):214\u201320.","journal-title":"Am J Cardiol"},{"issue":"11","key":"2186_CR5","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","volume":"138","author":"ASV Shah","year":"2018","unstructured":"Shah ASV, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, Longenecker CT, Strachan F, Bagchi S, Whiteley W, Rajagopalan S, Kottilil S, Nair H, Newby DE, McAllister DA, Mills NL. Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis. Circulation. 2018;138(11):1100\u201312.","journal-title":"Circulation"},{"issue":"1","key":"2186_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/HYPERTENSIONAHA.118.10893","volume":"72","author":"SA Fahme","year":"2018","unstructured":"Fahme SA, Bloomfield GS, Peck R. Hypertension in HIV-infected adults: novel pathophysiologic mechanisms. Hypertension. 2018;72(1):44\u201355.","journal-title":"Hypertension"},{"issue":"10","key":"2186_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11906-020-01089-3","volume":"22","author":"SK Masenga","year":"2020","unstructured":"Masenga SK, Elijovich F, Koethe JR, Hamooya BM, Heimburger DC, Munsaka SM, Laffer CL, Kirabo A. Hypertension and metabolic syndrome in persons with HIV. Curr Hypertens Rep. 2020;22(10):78.","journal-title":"Curr Hypertens Rep"},{"issue":"11","key":"2186_CR8","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1097\/HJH.0b013e32830ef5fb","volume":"26","author":"M Baekken","year":"2008","unstructured":"Baekken M, Os I, Sandvik L, Oektedalen O. Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy. J Hypertens. 2008;26(11):2126\u201333.","journal-title":"J Hypertens"},{"issue":"Suppl 2","key":"2186_CR9","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1097\/QAI.0b013e318186519c","volume":"49","author":"DP Kotler","year":"2008","unstructured":"Kotler DP. HIV and antiretroviral therapy: lipid abnormalities and associated cardiovascular risk in HIV-infected patients. J Acquir Immune Defic Syndr. 2008;49(Suppl 2):S79\u201385.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"2186_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1056\/NEJMra041811","volume":"352","author":"S Grinspoon","year":"2005","unstructured":"Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005;352(1):48\u201362.","journal-title":"N Engl J Med"},{"issue":"4","key":"2186_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/COH.0b013e3281e66919","volume":"2","author":"J Capeau","year":"2007","unstructured":"Capeau J. From lipodystrophy and insulin resistance to metabolic syndrome: HIV infection, treatment and aging. Curr Opin HIV AIDS. 2007;2(4):247\u201352.","journal-title":"Curr Opin HIV AIDS"},{"issue":"10","key":"2186_CR12","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1001\/archinte.165.10.1179","volume":"165","author":"TT Brown","year":"2005","unstructured":"Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA, Visscher BR, Margolick JB, Dobs AS. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med. 2005;165(10):1179\u201384.","journal-title":"Arch Intern Med"},{"issue":"6","key":"2186_CR13","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1161\/CIRCULATIONAHA.108.790857","volume":"119","author":"SW Worm","year":"2009","unstructured":"Worm SW, De Wit S, Weber R, Sabin CA, Reiss P, El-Sadr W, Monforte AD, Kirk O, Fontas E, Dabis F, Law MG, Lundgren JD, Friis-M\u00f8ller N. Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the data collection on adverse events of anti-HIV drugs (D:A:D study). Circulation. 2009;119(6):805\u201311.","journal-title":"Circulation"},{"issue":"6","key":"2186_CR14","doi-asserted-by":"publisher","first-page":"e003371","DOI":"10.1161\/JAHA.116.003371","volume":"5","author":"H Bahrami","year":"2016","unstructured":"Bahrami H, Budoff M, Haberlen SA, Rezaeian P, Ketlogetswe K, Tracy R, Palella F, Witt MD, McConnell MV, Kingsley L, Post WS. Inflammatory markers associated with subclinical coronary artery disease: the multicenter AIDS cohort study. J Am Heart Assoc. 2016;5(6):e003371.","journal-title":"J Am Heart Assoc"},{"issue":"13","key":"2186_CR15","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1097\/QAD.0000000000001149","volume":"30","author":"DC Hsu","year":"2016","unstructured":"Hsu DC, Ma YF, Hur S, Li D, Rupert A, Scherzer R, Kalapus SC, Deeks S, Sereti I, Hsue PY. Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive antiretroviral therapy. AIDS. 2016;30(13):2065\u201374.","journal-title":"AIDS"},{"issue":"9","key":"2186_CR16","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/infdis\/jix082","volume":"215","author":"DB Hanna","year":"2017","unstructured":"Hanna DB, Lin J, Post WS, Hodis HN, Xue X, Anastos K, Cohen MH, Gange SJ, Haberlen SA, Heath SL, Lazar JM, Liu C, Mack WJ, Ofotokun I, Palella FJ, Tien PC, Witt MD, Landay AL, Kingsley LA, Tracy RP, Kaplan RC. Association of macrophage inflammation biomarkers with progression of subclinical carotid artery atherosclerosis in HIV-infected women and men. J Infect Dis. 2017;215(9):1352\u201361.","journal-title":"J Infect Dis"},{"issue":"8","key":"2186_CR17","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/infdis\/jiu594","volume":"211","author":"RA McKibben","year":"2015","unstructured":"McKibben RA, Margolick JB, Grinspoon S, Li X, Palella FJ, Kingsley LA, Witt MD, George RT, Jacobson LP, Budoff M, Tracy RP, Brown TT, Post WS. Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection. J Infect Dis. 2015;211(8):1219\u201328.","journal-title":"J Infect Dis"},{"issue":"9","key":"2186_CR18","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1097\/QAD.0b013e32832b514b","volume":"23","author":"PY Hsue","year":"2009","unstructured":"Hsue PY, Hunt PW, Schnell A, Kalapus SC, Hoh R, Ganz P, Martin JN, Deeks SG. Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS. 2009;23(9):1059\u201367.","journal-title":"AIDS"},{"issue":"10","key":"2186_CR19","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1097\/QAD.0b013e32833ad914","volume":"24","author":"ES Ford","year":"2010","unstructured":"Ford ES, Greenwald JH, Richterman AG, Rupert A, Dutcher L, Badralmaa Y, Natarajan V, Rehm C, Hadigan C, Sereti I. Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection. AIDS. 2010;24(10):1509\u201317.","journal-title":"AIDS"},{"issue":"1","key":"2186_CR20","first-page":"208","volume":"80","author":"M Karmochkine","year":"1998","unstructured":"Karmochkine M, Ankri A, Calvez V, Bonmarchant M, Coutellier A, Herson S. Plasma hypercoagulability is correlated to plasma HIV load. Thromb Haemost. 1998;80(1):208\u20139.","journal-title":"Thromb Haemost"},{"issue":"3","key":"2186_CR21","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1086\/649897","volume":"201","author":"SW Worm","year":"2010","unstructured":"Worm SW, Sabin C, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, Monforte AD, Friis-M\u00f8ller N, Kirk O, Fontas E, Weller I, Phillips A, Lundgren J. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study. J Infect Dis. 2010;201(3):318\u201330.","journal-title":"J Infect Dis"},{"issue":"7","key":"2186_CR22","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/QAD.0000000000001783","volume":"32","author":"JA O\u2019Halloran","year":"2018","unstructured":"O\u2019Halloran JA, Dunne E, Tinago W, Denieffe S, Kenny D, Mallon PWG. Switching from abacavir to Tenofovir disoproxil fumarate is associated with rises in soluble glycoprotein VI, suggesting changes in platelet-collagen interactions. AIDS. 2018;32(7):861\u20136.","journal-title":"AIDS"},{"issue":"11","key":"2186_CR23","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1161\/CIRCRESAHA.119.316477","volume":"127","author":"AA Khawaja","year":"2020","unstructured":"Khawaja AA, Taylor KA, Lovell AO, Nelson M, Gazzard B, Boffito M, Emerson M. HIV antivirals affect endothelial activation and endothelial-platelet crosstalk. Circ Res. 2020;127(11):1365\u201380.","journal-title":"Circ Res"},{"issue":"5","key":"2186_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2459\/JCM.0000000000000767","volume":"20","author":"M Peyracchia","year":"2019","unstructured":"Peyracchia M, Verardi R, Rubin SR, Abu-Assi E, Montrucchio C, Perl L, Grossomarra W, Calcagno A, Omed\u00e8 P, Montefusco A, Bonora S, Moretti C, D\u2019Amico M, Mauro R, D\u2019Ascenzo F. In-hospital and long-term outcomes of HIV-positive patients undergoing PCI according to kind of stent: a meta-analysis. J Cardiovasc Med (Hagerstown). 2019;20(5):321\u20136.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"1","key":"2186_CR25","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12872-017-0624-0","volume":"17","author":"PK Bundhun","year":"2017","unstructured":"Bundhun PK, Pursun M, Huang WQ. Does infection with human immunodeficiency virus have any impact on the cardiovascular outcomes following percutaneous coronary intervention?: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2017;17(1):190.","journal-title":"BMC Cardiovasc Disord"},{"key":"2186_CR26","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"2","key":"2186_CR27","first-page":"192","volume":"85","author":"S Badr","year":"2015","unstructured":"Badr S, Minha S, Kitabata H, Fatemi O, Torguson R, Suddath WO, Satler LF, Pichard AD, Waksman R. Safety and long-term outcomes after percutaneous coronary intervention in patients with human immunodeficiency virus. Catheter Cardiovasc Interv. 2015;85(2):192\u20138.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"17","key":"2186_CR28","doi-asserted-by":"publisher","first-page":"e017578","DOI":"10.1161\/JAHA.119.017578","volume":"9","author":"F Boccara","year":"2020","unstructured":"Boccara F, Mary-Krause M, Potard V, Teiger E, Lang S, Hammoudi N, Chauvet M, Ederhy S, Dufour-Soulat L, Ancedy Y, Nhan P, Adavane S, Steg PG, Funck-Brentano C, Costagliola D, Cohen A, PACS-HIV (Prognosis of Acute Coronary Syndrome in HIV\u2010Infected Patients) Investigators. HIV infection and long-term residual cardiovascular risk after acute coronary syndrome. J Am Heart Assoc. 2020;9(17):e017578.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"2186_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/eurheartj\/ehq372","volume":"32","author":"F Boccara","year":"2011","unstructured":"Boccara F, Mary-Krause M, Teiger E, Lang S, Lim P, Wahbi K, Beygui F, Milleron O, Gabriel Steg P, Funck-Brentano C, Slama M, Girard PM, Costagliola D, Cohen A, Prognosis of Acute Coronary Syndrome in HIV-Infected Patients (PACS) Investigators. Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis. Eur Heart J. 2011;32(1):41\u201350.","journal-title":"Eur Heart J"},{"key":"2186_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12981-015-0045-z","volume":"12","author":"D Carballo","year":"2015","unstructured":"Carballo D, Delhumeau C, Carballo S, B\u00e4hler C, Radovanovic D, Hirschel B, Clerc O, Bernasconi E, Fasel D, Schmid P, Cusini A, Fehr J, Erne P, Keller PF, Ledergerber B, Calmy A, Swiss HIV. Cohort Study and AMIS Registry. Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study. AIDS Res Ther. 2015;12:4.","journal-title":"AIDS Res Ther"},{"issue":"3","key":"2186_CR31","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1161\/01.CIR.0000114520.38748.AA","volume":"109","author":"PY Hsue","year":"2004","unstructured":"Hsue PY, Giri K, Erickson S, MacGregor JS, Younes N, Shergill A, Waters DD. Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. Circulation. 2004;109(3):316\u20139.","journal-title":"Circulation"},{"issue":"12","key":"2186_CR32","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1089\/aid.2017.0128","volume":"33","author":"C Jeon","year":"2017","unstructured":"Jeon C, Lau C, Kendall CE, Burchell AN, Bayoumi AM, Loutfy M, Rourke SB, Antoniou T. Mortality and health service use following acute myocardial infarction among persons with HIV: a population-based study. AIDS Res Hum Retroviruses. 2017;33(12):1214\u20139.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"17","key":"2186_CR33","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1161\/CIRCULATIONAHA.113.001874","volume":"127","author":"L Lorgis","year":"2013","unstructured":"Lorgis L, Cottenet J, Molins G, Benzenine E, Zeller M, Aube H, Touzery C, Hamblin J, Gudjoncik A, Cottin Y, Quantin C. Outcomes after acute myocardial infarction in HIV-infected patients: analysis of data from a French nationwide hospital medical information database. Circulation. 2013;127(17):1767\u201374.","journal-title":"Circulation"},{"issue":"1","key":"2186_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/hiv.12670","volume":"20","author":"JL Marcus","year":"2019","unstructured":"Marcus JL, Hurley LB, Prasad A, Zaroff J, Klein DB, Horberg MA, Go AS, DeLorenze GN, Quesenberry CP Jr, Sidney S, Lo JC, Silverberg MJ. Recurrence after hospitalization for acute coronary syndrome among HIV-infected and HIV-uninfected individuals. HIV Med. 2019;20(1):19\u201326.","journal-title":"HIV Med"},{"issue":"4","key":"2186_CR35","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1001\/archinte.163.4.457","volume":"163","author":"S Matetzky","year":"2003","unstructured":"Matetzky S, Domingo M, Kar S, Noc M, Shah PK, Kaul S, Daar E, Cercek B. Acute myocardial infarction in human immunodeficiency virus-infected patients. Arch Intern Med. 2003;163(4):457\u201360.","journal-title":"Arch Intern Med"},{"issue":"3","key":"2186_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/ehjqcco\/qcaa088","volume":"7","author":"MM Parks","year":"2021","unstructured":"Parks MM, Secemsky EA, Yeh RW, Shen C, Choi E, Kazi DS, Hsue PY. Longitudinal management and outcomes of acute coronary syndrome in persons living with HIV infection. Eur Heart J Qual Care Clin Outcomes. 2021;7(3):273\u20139.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"8","key":"2186_CR37","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.amjcard.2012.05.045","volume":"110","author":"D Pearce","year":"2012","unstructured":"Pearce D, Ani C, Espinosa-Silva Y, Clark R, Fatima K, Rahman M, Diebolt E, Ovbiagele B. Comparison of in-hospital mortality from acute myocardial infarction in HIV sero-positive versus sero-negative individuals. Am J Cardiol. 2012;110(8):1078\u201384.","journal-title":"Am J Cardiol"},{"issue":"5","key":"2186_CR38","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ejim.2011.02.017","volume":"22","author":"R Perell\u00f3","year":"2011","unstructured":"Perell\u00f3 R, Calvo M, Mir\u00f3 O, Casta\u00f1eda M, Saub\u00ed N, Cam\u00f3n S, Foix A, Gatell JM, Masotti M, Mallolas J, S\u00e1nchez M, Martinez E. Clinical presentation of acute coronary syndrome in HIV infected adults: a retrospective analysis of a prospectively collected cohort. Eur J Intern Med. 2011;22(5):485\u20138.","journal-title":"Eur J Intern Med"},{"issue":"7","key":"2186_CR39","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1097\/QAD.0b013e3280b07dc6","volume":"21","author":"LD Rasmussen","year":"2007","unstructured":"Rasmussen LD, Gerstoft J, Kronborg G, Larsen CS, Pedersen G, Obel N. Mortality after myocardial infarction in HIV-infected patients who have initiated HAART. AIDS. 2007;21(7):873\u20135.","journal-title":"AIDS"},{"issue":"2","key":"2186_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.amjcard.2009.03.036","volume":"104","author":"X Ren","year":"2009","unstructured":"Ren X, Trilesskaya M, Kwan DM, Nguyen K, Shaw RE, Hui PY. Comparison of outcomes using bare metal versus drug-eluting stents in coronary artery disease patients with and without human immunodeficiency virus infection. Am J Cardiol. 2009;104(2):216\u201322.","journal-title":"Am J Cardiol"},{"issue":"14","key":"2186_CR41","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.4244\/EIJ-D-15-00409","volume":"12","author":"K Theodoropoulos","year":"2017","unstructured":"Theodoropoulos K, Mennuni MG, Sartori S, Meelu OA, Yu J, Baber U, Stefanini GG, Mastoris I, Moreno P, Dangas GD, Mehran R, Sharma SK, Kini AS. Quantitative angiographic characterisation of coronary artery disease in patients with human immunodeficiency virus (HIV) infection undergoing percutaneous coronary intervention. EuroIntervention. 2017;12(14):1757\u201365.","journal-title":"EuroIntervention"},{"issue":"3","key":"2186_CR42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/MCA.0000000000000488","volume":"28","author":"A Albaeni","year":"2017","unstructured":"Albaeni A, Harris C, Eid SM, Abougergi MS, Wright SM. HIV status and type of coronary stent placed in patients presenting with ST-elevation myocardial infarction. Coron Artery Dis. 2017;28(3):239\u201345.","journal-title":"Coron Artery Dis"},{"issue":"9","key":"2186_CR43","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3390\/diagnostics13091526","volume":"13","author":"M Bajdechi","year":"2023","unstructured":"Bajdechi M, Gurghean A, Bataila V, Scafa-Udriste A, Radoi R, Oprea AC, Marinescu A, Ion S, Chioncel V, Nicula A, Anastasiou A, Bajdechi GE, Savulescu-Fiedler I, Dumitru IM, Rugina S. Cardiovascular risk factors, angiographical features and short-term prognosis of acute coronary syndrome in people living with human immunodeficiency virus: results of a retrospective observational multicentric Romanian study. Diagnostics (Basel). 2023;13(9):1526.","journal-title":"Diagnostics (Basel)"},{"issue":"6","key":"2186_CR44","doi-asserted-by":"publisher","first-page":"e9849","DOI":"10.1097\/MD.0000000000009849","volume":"97","author":"ME Clement","year":"2018","unstructured":"Clement ME, Lin L, Navar AM, Okeke NL, Naggie S, Douglas PS. Lower likelihood of cardiac procedures after acute coronary syndrome in patients with human immunodeficiency virus\/acquired immunodeficiency syndrome. Med (Baltim). 2018;97(6):e9849.","journal-title":"Med (Baltim)"},{"issue":"15","key":"2186_CR45","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.medcli.2010.05.008","volume":"135","author":"R Mart\u00edn-Reyes","year":"2010","unstructured":"Mart\u00edn-Reyes R, Galeote G, Moreno R, S\u00e1nchez-Recalde A, L\u00f3pez De S\u00e1 E, L\u00f3pez-Send\u00f3n JL. [Percutaneous coronary intervention in HIV infected patients with human immunodeficiency virus admitted with acute coronary syndrome: case-control study]. Med Clin (Barc). 2010;135(15):691\u20134.","journal-title":"Med Clin (Barc)"},{"issue":"1","key":"2186_CR46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11606-019-05416-6","volume":"35","author":"GO Ogunbayo","year":"2020","unstructured":"Ogunbayo GO, Ha LD, Ahmad Q, Misumida N, Okwechime R, Elbadawi A, Abdel-Latif A, Elayi CS, Smyth S, Boccara F, Messerli AW. Treatment bias in management of HIV patients admitted for acute myocardial infarction: does it still exist? J Gen Intern Med. 2020;35(1):57\u201362.","journal-title":"J Gen Intern Med"},{"issue":"12","key":"2186_CR47","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1093\/infdis\/jiw082","volume":"213","author":"NL Okeke","year":"2016","unstructured":"Okeke NL, Hicks CB, McKellar MS, Fowler VG, Federspiel JJ. History of AIDS in HIV-infected patients is associated with higher in-hospital mortality following admission for acute myocardial infarction and stroke. J Infect Dis. 2016;213(12):1955\u201361.","journal-title":"J Infect Dis"},{"key":"2186_CR48","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.atherosclerosis.2018.05.001","volume":"274","author":"M Peyracchia","year":"2018","unstructured":"Peyracchia M, De Lio G, Montrucchio C, Omed\u00e8 P, d\u2019Ettore G, Calcagno A, Vullo V, Cerrato E, Pennacchi M, Sardella G, Manga P, GrossoMarra W, Vullo F, Fedele F, Biondi-Zoccai G, Moretti C, Vachiat A, Bonora S, Rinaldi M, Mancone M, D\u2019Ascenzo F. Evaluation of coronary features of HIV patients presenting with ACS: the CUORE, a multicenter study. Atherosclerosis. 2018;274:218\u201326.","journal-title":"Atherosclerosis"},{"issue":"12","key":"2186_CR49","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1111\/imj.14744","volume":"50","author":"A Postigo","year":"2020","unstructured":"Postigo A, D\u00edez-Delhoyo F, Devesa C, Bru\u00f1a V, Clavero-Olmos M, Vicent L, Ju\u00e1rez M, Sousa I, Fern\u00e1ndez-Avil\u00e9s F, Mart\u00ednez-Sell\u00e9s M. Clinical profile, anatomical features and long-term outcome of acute coronary syndromes in human immunodeficiency virus-infected patients. Intern Med J. 2020;50(12):1518\u201323.","journal-title":"Intern Med J"},{"issue":"5","key":"2186_CR50","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/joic.12433","volume":"30","author":"V Singh","year":"2017","unstructured":"Singh V, Mendirichaga R, Savani GT, Rodriguez AP, Dabas N, Munagala A, Alfonso CE, Cohen MG, Elmariah S, Palacios IF. Coronary revascularization for acute myocardial infarction in the HIV population. J Interv Cardiol. 2017;30(5):405\u201314.","journal-title":"J Interv Cardiol"},{"issue":"10","key":"2186_CR51","first-page":"403","volume":"28","author":"NR Smilowitz","year":"2016","unstructured":"Smilowitz NR, Gupta N, Guo Y, Coppola JT, Bangalore S. Influence of human immunodeficiency virus seropositive status on the in-hospital management and outcomes of patients presenting with acute myocardial infarction. J Invasive Cardiol. 2016;28(10):403\u20139.","journal-title":"J Invasive Cardiol"},{"issue":"3","key":"2186_CR52","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/QAI.0000000000002442","volume":"85","author":"S Vallabhajosyula","year":"2020","unstructured":"Vallabhajosyula S, Subramaniam AV, Sundaragiri PR, Cheungpasitporn W, Temesgen Z, O\u2019Horo JC, Jaffe AS, Barsness GW. Influence of human immunodeficiency virus infection on the management and outcomes of acute myocardial infarction with cardiogenic shock. J Acquir Immune Defic Syndr. 2020;85(3):331\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2186_CR53","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.atherosclerosis.2020.08.005","volume":"311","author":"SG Shitole","year":"2020","unstructured":"Shitole SG, Kuniholm MH, Hanna DB, Boucher T, Peng AY, Berardi C, Shah T, Bortnick AE, Christia P, Scheuer J, Kizer JR. Association of human immunodeficiency virus and hepatitis C virus infection with long-term outcomes post-ST segment elevation myocardial infarction in a disadvantaged urban community. Atherosclerosis. 2020;311:60\u20136.","journal-title":"Atherosclerosis"},{"issue":"9","key":"2186_CR54","doi-asserted-by":"publisher","first-page":"e025874","DOI":"10.1136\/bmjopen-2018-025874","volume":"9","author":"O Eyawo","year":"2019","unstructured":"Eyawo O, Brockman G, Goldsmith CH, Hull MW, Lear SA, Bennett M, Guillemi S, Franco-Villalobos C, Adam A, Mills EJ, Montaner JSG, Hogg RS. Risk of myocardial infarction among people living with HIV: an updated systematic review and meta-analysis. BMJ Open. 2019;9(9):e025874.","journal-title":"BMJ Open"},{"issue":"8","key":"2186_CR55","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","volume":"173","author":"MS Freiberg","year":"2013","unstructured":"Freiberg MS, Chang CCH, Kuller LH, Skanderson M, Lowy E, Kraemer KL, Butt AA, Bidwell Goetz M, Leaf D, Oursler KA, Rimland D, Rodriguez Barradas M, Brown S, Gibert C, McGinnis K, Crothers K, Sico J, Crane H, Warner A, Gottlieb S, Gottdiener J, Tracy RP, Budoff M, Watson C, Armah KA, Doebler D, Bryant K, Justice AC. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173(8):614\u201322.","journal-title":"JAMA Intern Med"},{"issue":"3","key":"2186_CR56","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/QAI.0b013e31821d33a5","volume":"57","author":"M Durand","year":"2011","unstructured":"Durand M, Sheehy O, Baril JG, Lelorier J, Tremblay CL. Association between HIV infection, antiretroviral therapy, and risk of acute myocardial infarction: a cohort and nested case-control study using Qu\u00e9bec\u2019s public health insurance database. J Acquir Immune Defic Syndr. 2011;57(3):245\u201353.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"2186_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/01.mca.0000236292.86930.e3","volume":"18","author":"P Maggi","year":"2007","unstructured":"Maggi P, Perilli F, Lillo A, Carito V, Epifani G, Bellacosa C, Pastore G, Regina G. An ultrasound-based comparative study on carotid plaques in HIV-positive patients vs. atherosclerotic and arteritis patients: atherosclerotic or inflammatory lesions? Coron Artery Dis. 2007;18(1):23\u20139.","journal-title":"Coron Artery Dis"},{"issue":"18","key":"2186_CR58","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1161\/01.CIR.102.18.2165","volume":"102","author":"V Pasceri","year":"2000","unstructured":"Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102(18):2165\u20138.","journal-title":"Circulation"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-024-02186-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-024-02186-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-024-02186-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T09:02:43Z","timestamp":1772096563000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-024-02186-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2186"],"URL":"https:\/\/doi.org\/10.1007\/s11886-024-02186-4","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"7 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No animal or human subjects by the authors were used in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"Jorge Plutzky reports consulting fees from Altimmune, Amgen, Boehringer Ingelheim, Esperion (clinical trial steering committee), Merck, New Amsterdam, Novo Nordisk (clinical trial steering committee, consultant), and Pfizer, outside the submitted work. Jorge Plutzky also reports grant support from Boehringer Ingelheim and Novartis, outside the submitted work. Emily P. Hyle reports personal fees from UpToDate, outside the submitted work. The other authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"84"}}